Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Microbiology Reviews

• Publication date

  2011-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/CMR.00044-10PMID 21233512PMCID PMC3021204
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Infectious mononucleosis.

  2024cited by this paper
• [Antiviral drugs].

  2011cited by this paper
• Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells.

  2010cited by this paper
• Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder

  2010cited by this paper
• Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets.

  2010cited by this paper
• The Epstein-Barr Virus (EBV)-Encoded Protein Kinase, EBV-PK, but Not the Thymidine Kinase (EBV-TK), Is Required for Ganciclovir and Acyclovir Inhibition of Lytic Viral Production

  2010cited by this paper
• A method for evaluating antiviral drug susceptibility of Epstein-Barr virus

  2010cited by this paper
• Optimal treatment for chronic active Epstein–Barr virus disease

  2009cited by this paper
• A Phase I Trial of Epstein-Barr Virus Gp350 Vaccine for Children With Chronic Kidney Disease Awaiting Transplantation

  2009influential reference
• The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway.

  2009cited by this paper
• Interlaboratory Comparison of Epstein‐Barr Virus Viral Load Assays

  2009cited by this paper
• EBV BMRF-2 facilitates cell-to-cell spread of virus within polarized oral epithelial cells.

  2009cited by this paper
• Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3

  2009cited by this paper
• Regulatory T cell activity in primary and persistent Epstein–Barr virus infection

  2009cited by this paper
• Evidence-Based Approach for Interpretation of Epstein-Barr Virus Serological Patterns

  2009cited by this paper
• Antiviral immune responses: triggers of or triggered by autoimmunity?

  2009cited by this paper
• The EBV-Encoded dUTPase Activates NF-κB through the TLR2 and MyD88-Dependent Signaling Pathway1

  2009cited by this paper
• Murine gammaherpesvirus 68 infection of IFNgamma unresponsive mice: a small animal model for gammaherpesvirus-associated B-cell lymphoproliferative disease.

  2009cited by this paper
• Long-Term Administration of Valacyclovir Reduces the Number of Epstein-Barr Virus (EBV)-Infected B Cells but Not the Number of EBV DNA Copies per B Cell in Healthy Volunteers

  2009cited by this paper
• The Epstein–Barr Virus Genome

  2009cited by this paper
• Fusion of epithelial cells by Epstein–Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins αvβ6 or αvβ8

  2009cited by this paper
• Outcome of treatment of Epstein–Barr virus‐related post‐transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

  2009influential reference
• SAP-controlled T-B cell interactions underlie germinal centre formation

  2008cited by this paper
• Monitoring of Epstein‐Barr virus load after hematopoietic stem cell transplantation for early intervention in post‐transplant lymphoproliferative disease

  2008cited by this paper
• Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation.

  2008cited by this paper
• On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis.

  2008influential reference
• Proposed categorization of pathological states of EBV‐associated T/natural killer‐cell lymphoproliferative disorder (LPD) in children and young adults: Overlap with chronic active EBV infection and infantile fulminant EBV T‐LPD

  2008cited by this paper
• A virtual look at Epstein-Barr virus infection: simulation mechanism.

  2008cited by this paper
• Evolutionary struggles between NK cells and viruses

  2008cited by this paper
• The Early Kinetics of Cytomegalovirus-Specific CD8+ T-Cell Responses Are Not Affected by Antigen Load or the Absence of Perforin or Gamma Interferon

  2008cited by this paper
• Oropharyngeal shedding of Epstein-Barr virus in the absence of circulating B cells.

  2008cited by this paper
• Immune escape by Epstein-Barr virus associated malignancies.

  2008cited by this paper
• Mononucleosis and Athletic Participation: An Evidence-Based Subject Review

  2008cited by this paper
• Interleukin‐10: new perspectives on an old cytokine

  2008cited by this paper
• Herpesvirus prevalence and viral load in healthy blood donors by quantitative real‐time polymerase chain reaction

  2008cited by this paper
• Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

  2007influential reference
• Adolescents Are More Likely to Develop Posttransplant Lymphoproliferative Disorder After Primary Epstein-Barr Virus Infection Than Younger Renal Transplant Recipients

  2007cited by this paper
• A virologic pilot study of valacyclovir in infectious mononucleosis.

  2007cited by this paper
• Herpesvirus latency confers symbiotic protection from bacterial infection

  2007cited by this paper
• Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults.

  2007cited by this paper
• Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis

  2007cited by this paper
• A study of risk factors for acquisition of Epstein-Barr virus and its subtypes.

  2007cited by this paper
• Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.

  2007influential reference
• Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.

  2007cited by this paper
• Characterization of the Epstein-Barr virus glycoprotein BMRF-2.

  2007cited by this paper
• Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus

  2007cited by this paper
• Multicenter Comparison of Different Real-Time PCR Assays for Quantitative Detection of Epstein-Barr Virus

  2007cited by this paper
• Clinical, Viral and Antibody Kinetics during Infectious Mononucleosis (IM)

  2007cited by this paper
• Real-time quantitative PCR for assessment of antiviral drug effects against Epstein-Barr virus replication and EBV late mRNA expression.

  2007cited by this paper
• In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection

  2007cited by this paper
• Epstein-Barr virus vaccine for the prevention of infectious mononucleosis--and what else?

  2007cited by this paper
• Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

  2007cited by this paper
• Pathogenesis of chronic active Epstein‐Barr virus infection: Is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?

  2006cited by this paper
• Antibodies to gp350/220 Enhance the Ability of Epstein-Barr Virus To Infect Epithelial Cells

  2006cited by this paper
• Steroids for symptom control in infectious mononucleosis.

  2006cited by this paper
• A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis.

  2006cited by this paper
• Memory of mice and men: CD8+ T‐cell cross‐reactivity and heterologous immunity

  2006cited by this paper
• Treatment of PTLD with Rituximab or Chemotherapy

  2006cited by this paper
• Clinical inquiries. What test is the best for diagnosing infectious mononucleosis?

  2006cited by this paper
• Cells lytically infected with Epstein-Barr virus are detected and separable by immunoglobulins from EBV-seropositive individuals.

  2006cited by this paper
• A Randomized Trial of Ganciclovir versus Ganciclovir Plus Immune Globulin for Prophylaxis Against Epstein-Barr Virus Related Posttransplant Lymphoproliferative Disorder

  2006cited by this paper
• Significance of Epstein-Barr virus (EBV) load and Interleukin-10 in post-transplant lymphoproliferative disorders

  2005cited by this paper
• A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis.

  2005cited by this paper
• The immune response to primary EBV infection: a role for natural killer cells

  2005influential reference
• Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.

  2005cited by this paper
• Reactivation of Epstein‐Barr virus from latency

  2005cited by this paper
• Regulation of NKT cell development by SAP, the protein defective in XLP

  2005cited by this paper
• Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature

  2005cited by this paper
• Long-term shedding of infectious epstein-barr virus after infectious mononucleosis.

  2005cited by this paper
• Infectious mononucleosis and corticosteroids: management practices and outcomes.

  2005cited by this paper
• Mononucleosis in the laboratory.

  2005cited by this paper
• Meta-Analysis: The Efficacy of Strategies To Prevent Organ Disease by Cytomegalovirus in Solid Organ Transplant Recipients

  2005cited by this paper
• Proposed guidelines for diagnosing chronic active Epstein‐Barr virus infection

  2005cited by this paper
• Latent and lytic Epstein‐Barr virus replication strategies

  2005cited by this paper
• False-Positive Result Provided by Rapid Heterophile Antibody Test in a Case of Acute Infection with Hepatitis E Virus

  2004cited by this paper
• Epstein–Barr virus: 40 years on

  2004cited by this paper
• High Th1-type cytokine serum levels in patients with infectious mononucleosis.

  2004cited by this paper
• Prevalence of Epstein-Barr virus antibodies in healthy children and adolescents in Vitória, State of Espírito Santo, Brazil.

  2004cited by this paper
• Persistence of the Epstein-Barr virus and the origins of associated lymphomas.

  2004influential reference
• Acute Infection with Epstein-Barr Virus Targets and Overwhelms the Peripheral Memory B-Cell Compartment with Resting, Latently Infected Cells

  2004cited by this paper
• Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.

  2004cited by this paper
• Epstein-Barr Virus Infection in Ex Vivo Tonsil Epithelial Cell Cultures of Asymptomatic Carriers

  2004cited by this paper
• Cellular therapy of Epstein-Barr-virus-associated post-transplant lymphoproliferative disease.

  2004cited by this paper
• Infectious mononucleosis: return to play.

  2004influential reference
• Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy.

  2004cited by this paper
• Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.

  2004cited by this paper
• Routine Epstein-Barr Virus Diagnostics from the Laboratory Perspective: Still Challenging after 35 Years

  2004cited by this paper
• Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children

  2003cited by this paper
• Mechanism of action of glycyrrhizic acid in inhibition of Epstein-Barr virus replication in vitro.

  2003cited by this paper
• Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells

  2003cited by this paper
• Measurement of Epstein-Barr Virus DNA Loads in Whole Blood and Plasma by TaqMan PCR and in Peripheral Blood Lymphocytes by Competitive PCR

  2003cited by this paper
• Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults

  2003influential reference
• High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment

  2003cited by this paper
• Post-transplant lymphoproliferative disorder: a review

  2003cited by this paper
• Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells

  2003cited by this paper
• Molecular biology of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus.

  2003cited by this paper
• Differential Kinetics and Specificity of EBV-Specific CD4+ and CD8+ T Cells During Primary Infection1

  2003cited by this paper
• Alternate replication in B cells and epithelial cells switches tropism of Epstein–Barr virus

  2002cited by this paper
• Sexual history and Epstein-Barr virus infection.

  2002cited by this paper
• A systematic study of Epstein-Barr virus serologic assays following acute infection.

  2002cited by this paper

• Tonsillar Microbial Signature of Fusobacterium nucleatum Associated With Epstein‐Barr Virus Latency

  2026cites this paper
• Detection of Cyvirus cyprinidallo 2 in asymptomatic survival gibel carp, Carassius auratus gibelio after a secondary Aeromonas veronii infection

  2026cites this paper
• AIM2-mediated pyroptosis correlates with viral load and liver injury in children with primary Epstein-Barr virus infection.

  2026cites this paper
• Descriptive Case Series of Childhood Lymphomas Treated at the Children's Hospital of Mexico.

  2026cites this paper
• A Deep Dive Into Oncogenic Viruses Understanding Their Role in Cancer and Approaches for Prevention.

  2026cites this paper
• Comprehensive resolution and classification of the Epstein Barr virus transcriptome

  2025cites this paper
• Longitudinally Extensive Transverse Myelitis (LETM) and Meningoencephalitis Following Acute Epstein-barr Virus Infection in an Immunocompetent Male: Case Report and Review Literature.

  2025cites this paper
• Relationship between anti-Epstein-Barr virus early antigen diffuse type and restricted type immunoglobulin G antibodies and disease activity and autoantibodies in rheumatoid arthritis: a retrospective observational study

  2025cites this paper
• Comprehensive immunoinformatics and structural biology based design for novel peptide vaccines against Epstein-Barr virus

  2025cites this paper
• The Many Faces of Primary EBV Infection: A Case Series of Its Diverse Presentations

  2025cites this paper
• Oncoviruses in the Oral Cavity: Recent Advances in Understanding Viral Infections and Tumorigenesis

  2025cites this paper
• Rash associated with antibiotic administration in patients with infectious mononucleosis: a systematic review and meta-analysis

  2025cites this paper
• Bitemporal Oedema in a Child: A Rare Manifestation of Epstein–Barr Virus Infection

  2025cites this paper
• Manifestations of EBV infection in children

  2025influential citation
• Infectious Mononucleosis.

  2025cites this paper
• Exploring the Association between Epstein-Barr Virus and Systemic Lupus Erythematosus: Insights into Viral Triggers

  2025cites this paper
• Risk of infectious mononucleosis is not associated with prior infection morbidity

  2025cites this paper
• ETS Translocation Variant 5 Negatively Modulates Innate Immunity to Facilitate Epstein‐Barr Virus Reactivation

  2025cites this paper
• Early circulating EBV-DNA clearance predicts enhanced short-term treatment response and survival benefit in locally advanced nasopharyngeal carcinoma

  2025cites this paper
• Development of a Diagnostic Algorithm for Epstein‐Barr Virus‐Related Diseases: A Retrospective Observational Study

  2025cites this paper
• Reactivation of Latent Tuberculosis Following COVID-19 and Epstein-Barr Virus Coinfection: A Case Report

  2025cites this paper
• Population-Based Incidence of Infectious Mononucleosis and Related Hospitalizations: 2010 Through 2021.

  2025cites this paper
• Associations between past infectious mononucleosis diagnosis and 47 inflammatory and vascular stress biomarkers

  2025cites this paper
• Epidemiological characteristics of infectious mononucleosis among hospitalized children in Henan Province, China: a retrospective study

  2025cites this paper
• Molecular mechanisms of viral oncogenesis in haematological malignancies: perspectives from metabolic reprogramming, epigenetic regulation and immune microenvironment remodeling

  2025cites this paper
• Epidemiology of Epstein-Barr Virus Chronic High Viral Load in Kidney Transplant Recipients

  2024cites this paper
• Epstein-Barr virus: the mastermind of immune chaos

  2024cites this paper
• Two cases of misleading Epstein-Barr virus infection and the role of EBV-DNA

  2024influential citation
• Infectious factors in myocarditis: a comprehensive review of common and rare pathogens

  2024cites this paper
• Analytical and clinical evaluation of the cobas Epstein-Barr virus test at a tertiary care cancer hospital.

  2024cites this paper
• Role of Epstein-Barr Virus in Breast Cancer: Correlation with Clinical Outcome and Survival Analysis

  2024cites this paper
• Epstein-Barr Virus-Positive Mucosal Skin Ulcer Resulting in Oral Lesions During Concomitant Use of Tacrolimus and Prednisolone

  2024cites this paper
• Novel plasma microRNA expression features in diagnostic use for Epstein-Barr virus-associated febrile diseases

  2024cites this paper
• Could Herpesviridae be the cause of severe acute hepatitis of unknown origin in children?

  2024cites this paper
• Epstein–Barr Virus: Human Interactome Reveals New Molecular Insights into Viral Pathogenesis for Potential Therapeutics and Antiviral Drug Discovery

  2024cites this paper
• Immunodiagnostic investigations for children with lymphadenopathy at Tanta University hospital

  2024cites this paper
• Clinical efficacy of ganciclovir combined with transfer factor oral solution for pediatric infectious mononucleosis

  2024cites this paper
• Epstein–Barr Viruses: Their Immune Evasion Strategies and Implications for Autoimmune Diseases

  2024influential citation
• One step 4× and 12× 3D-ExM enables robust super-resolution microscopy of nanoscale cellular structures

  2024cites this paper
• A comprehensive review of research advances in the study of lactoferrin to treat viral infections.

  2024cites this paper
• Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation

  2024cites this paper
• An In Silico Approach to Discover Efficient Natural Inhibitors to Tie Up Epstein–Barr Virus Infection

  2024cites this paper
• The role of PRMT1 in cellular regulation and disease: Insights into biochemical functions and emerging inhibitors for cancer therapy.

  2024cites this paper
• EBNA1BP2 identified as potential prognostic biomarker for multiple tumor types in pan-cancer analysis

  2024cites this paper
• mRNA vaccine design for Epstein–Barr virus: an immunoinformatic approach

  2024cites this paper
• Epstein‐Barr virus in tonsillar tissue of Iranian children with tonsillar hypertrophy: Quantitative measurement by real‐time PCR

  2024cites this paper
• Epstein–Barr Virus‐Associated Lymphoproliferative Disorders/Lymphoma with Skin Manifestations as the Primary Symptom: A Systematic Review

  2024cites this paper
• Coinfection of EBV with other pathogens: a narrative review

  2024cites this paper
• One step 4x and 12x 3D-ExM: robust super-resolution microscopy in cell biology

  2024cites this paper
• Expression of Anti- Apoptotic Gene ( BARF1) and Immunomodulatory Gene (BCRF1) For Epstein Barr Virus in Chronic Active EBV Patients

  2024cites this paper
• Characteristics of immunological events in Epstein-Barr virus infection in children with infectious mononucleosis

  2023cites this paper
• Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell Lymphoma

  2023cites this paper
• Role of Exosomes and Their Potential as Biomarkers in Epstein-Barr Virus-Associated Gastric Cancer

  2023cites this paper
• Acute Epstein-Barr virus Encephalitis and hepatitis without mononucleosis syndrome: a case report

  2023cites this paper
• Different routes of MHC-I delivery to phagosomes and their consequences to CD8 T cell immunity.

  2023cites this paper
• Is There an Association between Concurrent Epstein–Barr Virus Infection and Sudden Hearing Loss?—A Case—Control Study in an East Asian Population

  2023cites this paper
• Human Oncogenic Epstein–Barr Virus in Water and Human Blood Infection of Communities in Phayao Province, Thailand

  2023cites this paper
• ‘A kiss that took my legs away’: a rare presentation of Epstein–Barr virus in the older population

  2023cites this paper
• A modified multiple cross displacement amplification linked with a gold nanoparticle biosensor for the detection of Epstein-Barr virus in clinical applications

  2023influential citation
• Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival

  2023cites this paper
• Alzheimer ’ s disease as a viral disease: Revisiting the infectious hypothesis ☆

  2023influential citation
• EBV-induced T-cell responses in EBV-specific and nonspecific cancers

  2023cites this paper
• Asymptomatic viruses detectable in saliva in the first year of life: a narrative review

  2023cites this paper
• Epstein-Barr virus infection: the micro and macro worlds

  2023cites this paper
• Epstein-Barr virus induced acute hepatitis with hyperferritinemia: A rare presentation

  2023cites this paper
• A germ-free humanized mouse model shows the contribution of resident microbiota to human-specific pathogen infection

  2023cites this paper
• Evaluating the diagnostic performance of Liaison® chemiluminescence assay as screening tool for detection of acute Epstein-Barr infection: A comparative study.

  2023cites this paper
• The Impact of Co-Infections for Human Gammaherpesvirus Infection and Associated Pathologies

  2023cites this paper
• Bioinformatics analysis to screen the key genes in pediatric Chronic Active Epstein-Barr Virus Infection.

  2023cites this paper
• Therapeutic strategy for oncovirus-mediated oral cancer: A comprehensive review.

  2023cites this paper
• Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients

  2023cites this paper
• Chronic Epstein-Barr virus infection: A potential junction between primary Sjögren's syndrome and lymphoma.

  2023cites this paper
• Immunological Aspects of EBV and Oral Mucosa Interactions in Oral Lichen Planus

  2023influential citation
• Infectious Mononucleosis: An Updated Review.

  2023cites this paper
• TAP-ing into the cross-presentation secrets of dendritic cells.

  2023cites this paper
• Fever with atypical lymphocytosis: pearls and pitfalls in Epstein-Barr virus serology

  2023cites this paper
• T cell-mediated immunity during Epstein-Barr virus infections in children.

  2023cites this paper
• Malignancy and viral infections in Sub-Saharan Africa: A review

  2023cites this paper
• Clinical features of Talaromyces marneffei infection in HIV-positive and HIV-negative individuals: a retrospective study in southern China.

  2023cites this paper
• Bioinformatics analysis of the pathogenic link between Epstein-Barr virus infection, systemic lupus erythematosus and diffuse large B cell lymphoma

  2023cites this paper
• 嵌合抗原受体T细胞靶向LMP1抗原治疗EB病毒阳性淋巴瘤的功能研究

  2022cites this paper
• Diminished Cellular Immunity and Executive Cognitive Functioning Among Middle-Aged and Elderly Adults

  2022cites this paper
• Acute Dacryoadenitis due to Primary Epstein-Barr Virus Infection

  2022cites this paper
• A high-throughput real-time PCR tissue-of-origin test to distinguish blood from lymphoblastoid cell line DNA for (epi)genomic studies

  2022cites this paper
• Detection of EBV and CMV coinfection among patients under hemodialysis

  2022cites this paper
• Viêm gan tự miễn khởi phát sau nhiễm Epstein-Barr virus: Báo cáo ca bệnh

  2022cites this paper
• Prolonged Fever, Travel, and the Changing Examination in an 8-year-old Girl.

  2022cites this paper
• A case of Epstein-Barr virus acute retinal necrosis successfully treated with foscarnet

  2022cites this paper
• Comparison of Elecsys and Liaison immunoassays to determine Epstein–Barr virus serological status using further diagnostic approaches to clarify discrepant results

  2022cites this paper
• A brief overview of the Epstein Barr virus and its association with Burkitt's lymphoma

  2022cites this paper
• Multimodality imaging findings of infection-induced tumors

  2022influential citation
• Molecular Pathology of Gastric Cancer

  2022cites this paper
• Effects of Exosomal Viral Components on the Tumor Microenvironment

  2022cites this paper
• CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases

  2022cites this paper
• Chronic active Epstein-Barr exacerbated by COVID-19 co-infection

  2022cites this paper
• The Prevalence and the Patterns of the Expression of Latent Epstein-Barr Virus in Hodgkin’s and Non-Hodgkin’s Lymphomas Among Patients in Oman: Immunohistochemistry Versus in Situ Hybridization.

  2022cites this paper
• Epstein-Barr Virus and Malaria Interactions: Immunology Perspective

  2022cites this paper
• Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer

  2022cites this paper
• Plasma Immunoglobulin-G (IgG) Against Epstein Barr Virus Nuclear Antigens Among University Students in Port Harcourt, Nigeria

  2022cites this paper
• A Case of Warm Autoimmune Hemolytic Anemia Secondary to Epstein-Barr Virus Infection

  2022cites this paper